Dopaminergic drugs cause changes in deep brain areas of Parkinson's patient

November 30, 2016, Netherlands Organisation for Scientific Research (NWO)
Dopaminergic drugs cause changes in deep brain areas of Parkinson's patient
Credit: Hilary Morgan / Alamy

A drug like levodopa, which is used by patients with Parkinson's disease, causes changes in the communication between deep brain areas that are important for learning and behaviour. As a result of this, impulse control disorders such as gambling addiction or hypersexuality can occur. PhD researcher Payam Piray demonstrated this during research carried out at the Donders Institute in Nijmegen. He will defend his doctoral thesis on Thursday 1 December 2016. His research was funded with a grant from the NWO Free Competition.

In Parkinson's disease, the functioning of cells in the substantia nigra of the brain is disrupted. Accumulation of the protein alpha-synuclein plays an important role. The cells gradually die, a dopamine deficit arises in the brain and the regulatory circuits become disrupted. This gives rise to a wide range of symptoms such as tremors and stiffness. The process of protein accumulation and cell mortality cannot be prevented, but the dopamine can be supplemented via drugs. This reduces the symptoms, even though the effect is often only temporary.

Such 'dopaminergic' drugs have their own side effects. The substance levodopa, for example, which is one of the best-known Parkinson drugs, can cause in patients. These include such disorders as gambling or sexual addiction. Payam Piray investigated the correlation between the use of the drugs and the behavioural changes in the patient.

Learning and behaviour

Piray: 'Using refined computational techniques, we have demonstrated that with the use of dopaminergic drugs, people are no longer able to adequately learn from the positive and negative consequences of their behaviour. With the help of computational and brain scanning techniques, we discovered that these drugs alter the communication between the deep brain areas that are important for learning and behaviour. The exact effect depends on how impulsive a patient is before he or she starts taking the drugs: dopamine-stimulating drugs increase brain communication in people with an impulsive personality, but reduce it in people who are not impulsive by nature.'

This research illustrates the power of combining the computational and brain sciences, says Piray. 'As a consequence, we are able to better understand the brain and behaviour. Nearly all effects in this research could be isolated thanks to the use of . Without those techniques, we might have concluded that dopaminergic drugs have little effect on our brain and behaviour. Now we know how such drugs work in the , which consequences they have on and whom this affects.'

Explore further: Brain mechanisms in drug addiction—new brain pathways revealed

More information: Project page: … jects/i/83/6983.html

Related Stories

Brain mechanisms in drug addiction—new brain pathways revealed

November 24, 2016
UNSW researchers have identified new brain pathways linked to addiction and shown that by manipulating them, drug seeking behaviour and motivation for alcohol can be reduced.

Computer modeling shows how medications play a part in the Parkinson's experience

September 11, 2012
(Medical Xpress)—A University of Western Sydney researcher has developed a new computational model, which will improve our understanding of how Parkinson's disease (PD) medications affect the brain and cognition.

Parkinson's disease meds increase risk of compulsive gambling, shopping, binge eating

April 5, 2016
Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, report neurologists ...

REM sleep behavior disorder is a risk factor for Parkinson's disease

July 29, 2011
Patients suffering REM sleep behaviour disorders dream nightmares in which they are attacked and pursued, with the particularity that they express them by screaming, crying, punching and kicking while sleeping. Lancet Neurology ...

New light shed on causes of movement disorders Parkinson's disease

April 26, 2016
A possible cause has been found for the disrupted communication between brain cells exhibited by Parkinson's patients. Bettina Schwab, a researcher at the University of Twente, discovered that this group of patients have ...

Silent stroke can cause Parkinson's disease

December 18, 2012
(Medical Xpress)—Scientists at The University of Manchester have for the first time identified why a patient who appears outwardly healthy may develop Parkinson's disease.

Recommended for you

Parkinson's disease 'jerking' side effect detected by algorithm

January 8, 2018
A mathematical algorithm that can reliably detect dyskinesia, the side effect from Parkinson's treatment that causes involuntary jerking movements and muscle spasms, could hold the key to improving treatment and for patients ...

New brainstem changes identified in Parkinson's disease

January 4, 2018
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Researchers shed light on why exercise slows progression of Parkinson's disease

December 22, 2017
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.

Robotic device improves balance and gait in Parkinson's disease patients

December 19, 2017
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years ...

New findings point to potential therapy for Parkinson's Disease

December 19, 2017
A new study, published in Proceedings of the National Academy of Sciences (PNAS), sheds light on a mechanism underlying Parkinson's disease and suggests that Tacrolimus—an existing drug that targets the toxic protein interaction ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.